The same conclusion was raised by Ewald F. et al. [38] showing, in preclinical studies, how combined targeting of mTOR and AKT using RAD001 and MK-2206 inhibited the growth of CCA cell lines. This evidence concerns the gene AKT1 and cholangiocarcinoma.